BRÈVE

sur SingleTimeMicroneedles, Inc

SingleTimeMicroneedles Wins at 2024 SXSW Pitch Competition

SingleTimeMicroneedles, Inc., a pioneering microneedle drug development and delivery firm, clinched victory in the Food, Nutrition, and Health category at the 15th annual SXSW Pitch competition. In an event primarily overwhelmed by AI innovations, STM's distinctive approach marked a significant departure.

At the South by Southwest® Conference & Festivals, STM, led by CEO Jasdeep Singh, showcased its technology to a live audience and a panel of judges, triumphing over immense competition. Singh impressed the jury with his detailed answers and compelling narratives, emphasizing the company's mission to radically enhance health worldwide.

STM's groundbreaking microneedle delivery platform introduces a revolutionary method for administering drugs and vaccines, eliminating the need for cold-chain storage and enabling immediate or scheduled doses. This innovation has vast potential for both animal and human health applications, promising to transform access to critical pharmaceuticals globally.

Reflecting on the win, Research Lead Nicholas Farrell highlighted the significance of STM's achievement at SXSW, attributing their success to Singh's effective communication of the technology's global impact potential.

Following this victory, SingleTimeMicroneedles is poised for rapid growth, seeking partnerships to further its mission in the global health sector.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de SingleTimeMicroneedles, Inc